Murphy L C, Sutherland R L
Endocrinology. 1983 Feb;112(2):707-14. doi: 10.1210/endo-112-2-707.
As the polynucleotide domain of the estrogen receptor (Re) is a possible site for the modulation of Re activity, the interaction of antiestrogen (4-hydroxytamoxifen and tamoxifen)-receptor complexes (4-OH-Tam-Re and Tam-Re) with polynucleotides (oligodeoxynucleotide-cellulose, DNA-cellulose, and polyribonucleotide-agarose) was investigated and compared with that of the 17 beta-estradiol-receptor complex (E2-Re). E2-Re- and anti-Re-E2-complexes were optimally bound to oligo(dT)-cellulose and poly(U)-agarose at 0.15 M KCl and pH 7.6. Temperature activation of the Re was not required for these selective interactions to occur, but they were inhibited by 10 mM sodium molybdate. OH-Tam-Re and E2-Re demonstrated similar selectivity for different deoxynucleotide bases [oligo(dG) greater than oligo(dT) greater than or equal than oligo(dC) greater than oligo(dA) greater than or equal to oligo(dI)] and different ribonucleotide bases [poly(G) = poly(I) greater than poly(U) greater than poly(A) greater than or equal to poly(C)]. Quantitatively, Tam-Re bound significantly less to oligo(dT)-cellulose than did OH-Tam-Re, which did not differ significantly from E2-Re, a result probably related to the dissociation of the lower affinity ligand from the Re/oligo(dT)-cellulose during the assay procedure. Unoccupied Re also bound selectively to these synthetic polynucleotides. It is concluded that: 1) selective binding of Re to synthetic polynucleotides is inhibited by 10 mM sodium molybdate; 2) estradiol is not essential for selective binding to synthetic polynucleotides, since unoccupied Re was only slightly less efficiently bound than E2-Re; and 3) selective binding of Re to synthetic polynucleotides was unaffected by the agonist or antagonist properties of the ligand bound at the steroid-binding site. These data suggest that nonsteroidal antiestrogens are unlikely to exert their antagonist activity by modulating the function of the polynucleotide-binding site of Re.
由于雌激素受体(Re)的多核苷酸结构域可能是调节Re活性的位点,因此研究了抗雌激素(4-羟基他莫昔芬和他莫昔芬)-受体复合物(4-OH-Tam-Re和Tam-Re)与多核苷酸(寡脱氧核苷酸-纤维素、DNA-纤维素和聚核糖核苷酸-琼脂糖)的相互作用,并与17β-雌二醇-受体复合物(E2-Re)进行了比较。E2-Re和抗Re-E2复合物在0.15M KCl和pH 7.6条件下与寡聚(dT)-纤维素和聚(U)-琼脂糖的结合最佳。这些选择性相互作用的发生不需要对Re进行温度激活,但它们会被10mM钼酸钠抑制。OH-Tam-Re和E2-Re对不同的脱氧核苷酸碱基[寡聚(dG)>寡聚(dT)≥寡聚(dC)>寡聚(dA)≥寡聚(dI)]和不同的核糖核苷酸碱基[聚(G)=聚(I)>聚(U)>聚(A)≥聚(C)]表现出相似的选择性。定量分析表明,Tam-Re与寡聚(dT)-纤维素的结合明显少于OH-Tam-Re,而OH-Tam-Re与E2-Re无显著差异,这一结果可能与在测定过程中低亲和力配体从Re/寡聚(dT)-纤维素上解离有关。未占据的Re也选择性地与这些合成多核苷酸结合。结论如下:1)10mM钼酸钠可抑制Re与合成多核苷酸的选择性结合;2)雌二醇对于与合成多核苷酸的选择性结合并非必不可少,因为未占据的Re的结合效率仅略低于E2-Re;3)Re与合成多核苷酸的选择性结合不受甾体结合位点上结合的配体的激动剂或拮抗剂性质的影响。这些数据表明,非甾体类抗雌激素不太可能通过调节Re的多核苷酸结合位点的功能来发挥其拮抗活性。